Earnings in Focus: P10, Zymeworks, Gevo, and WalkMe Gear Up
- August 06th, 2023
- 719 views
A lineup of companies is gearing up to unveil their financial performance on Thursday, August 10, providing valuable insights into their recent activities and market dynamics, including:
P10, Inc. (NYSE: PX), a versatile company, is scheduled to release its second-quarter 2023 results following the close of U.S. markets.
Analysts' consensus points to an anticipated EPS of $0.18 on revenue totaling $57.13 million.
$PX closed at $11.83 on Friday, up $0.24 (+2.07%).
Zymeworks Inc. (Nasdaq: ZYME), a notable player in the biotechnology sector, will be reporting its second-quarter 2023 financial results after the market closes.
Market analysts are expecting a loss of $0.47 per share on revenue amounting to $12.36 million.
On Friday, $ZYME closed at $7.39, reflecting a gain of $0.07 (+0.96%).
Gevo, Inc. (Nasdaq: GEVO), a company focused on sustainable solutions, is set to reveal its financial results for the second quarter of 2023 following the close of the market.
The consensus estimate points to a loss of $0.05 per share on revenue totaling $4 million.
$GEVO closed at $1.57 on Friday, down $0.02 (-1.25%).
WalkMe Ltd. (Nasdaq: WKME), a leader in digital adoption, will release its second-quarter 2023 financial results before the opening of U.S. markets.
Analysts are forecasting a loss of $0.07 per share with revenue projected to reach $65.7 million.
On Friday, $WKME closed at $8.73, marking an increase of $0.08 (+0.92%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026




Member Login